Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$1.33 - $2.35 $9,975 - $17,625
-7,500 Reduced 27.26%
20,010 $37,000
Q1 2022

May 12, 2022

SELL
$1.86 - $3.24 $51,987 - $90,558
-27,950 Reduced 50.4%
27,510 $54,000
Q4 2021

Feb 10, 2022

SELL
$2.2 - $4.01 $218,270 - $397,848
-99,214 Reduced 64.14%
55,460 $130,000
Q3 2021

Nov 12, 2021

SELL
$3.34 - $4.63 $327,309 - $453,726
-97,997 Reduced 38.78%
154,674 $516,000
Q2 2021

Aug 11, 2021

SELL
$3.38 - $5.71 $62,925 - $106,303
-18,617 Reduced 6.86%
252,671 $968,000
Q1 2021

May 11, 2021

BUY
$3.77 - $6.05 $72,342 - $116,093
19,189 Added 7.61%
271,288 $1.46 Million
Q4 2020

Feb 11, 2021

SELL
$3.12 - $4.08 $21,999 - $28,768
-7,051 Reduced 2.72%
252,099 $933,000
Q3 2020

Nov 09, 2020

BUY
$3.09 - $4.14 $212,956 - $285,320
68,918 Added 36.23%
259,150 $975,000
Q2 2020

Aug 12, 2020

BUY
$1.47 - $2.97 $88,435 - $178,675
60,160 Added 46.25%
190,232 $565,000
Q1 2020

May 11, 2020

BUY
$1.57 - $3.1 $117,820 - $232,639
75,045 Added 136.38%
130,072 $205,000
Q4 2019

Feb 06, 2020

BUY
$2.72 - $3.15 $53,608 - $62,083
19,709 Added 55.8%
55,027 $170,000
Q3 2019

Nov 07, 2019

BUY
$2.58 - $3.97 $91,120 - $140,212
35,318 New
35,318 $113,000

About MediWound Ltd.


  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $789M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.